Trials / Conditions / Childhood Central Nervous System Germ Cell Tumor

Childhood Central Nervous System Germ Cell Tumor

16 registered clinical trials studyying Childhood Central Nervous System Germ Cell Tumor.

Status	Trial	Sponsor	Phase
Completed	Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Cent NCT00994500	National Cancer Institute (NCI)	Phase 1
Completed	ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors NCT00946335	National Cancer Institute (NCI)	Phase 1
Completed	Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Tr NCT00929903	National Cancer Institute (NCI)	Phase 1
Completed	Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagn NCT00638898	City of Hope Medical Center	Phase 1
Completed	Sunitinib in Treating Young Patients With Refractory Solid Tumors NCT00387920	National Cancer Institute (NCI)	Phase 1
Completed	Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma NCT00363272	National Cancer Institute (NCI)	Phase 1
Completed	AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors NCT00326664	National Cancer Institute (NCI)	Phase 1
Completed	Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors NCT00281944	National Cancer Institute (NCI)	Phase 1
Completed	Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas NCT00101270	National Cancer Institute (NCI)	Phase 1
Completed	Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors NCT00100880	National Cancer Institute (NCI)	Phase 1
Completed	Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatme NCT00091182	National Cancer Institute (NCI)	Phase 2
Completed	Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors NCT00919750	Children's Oncology Group	—
Completed	Cilengitide in Treating Children With Refractory Primary Brain Tumors NCT00063973	National Cancer Institute (NCI)	Phase 1
Completed	Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors NCT00052780	National Cancer Institute (NCI)	Phase 1
Completed	FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia NCT00053963	National Cancer Institute (NCI)	Phase 1
Completed	Irinotecan in Treating Children With Refractory Solid Tumors NCT00004078	Children's Oncology Group	Phase 2